AzTrials
AzTrials

Pain, AcuteNCT03450798

SOFT Block Versus Spinal Anesthesia in Patientsusing Ilizarov External Fixator

A study testing SOFT block group and spinal anesthesia group in people with Pain, Acute, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Peripheral nerve block is an ideal choice for lower limb surgery because of the peripheral site of the surgical procedure and the ability to block pain pathways at multiple levels. Read more about this study

Who is it for?
Ages 35 to 57 years
Conditions the study is for
Pain, Acute
What is being tested?
SOFT block group and spinal anesthesia group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
107 participants
Where
1 siteEgypt
Study dates
10 Feb 2018to 10 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 57 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 35 to 57 years old
  • ASA I,II
  • BMI<30
  • fixation of open tibial fractures using Ilizarov external fixator -

Who cannot join

  • Refusal to participate,
  • Inability to communicate with the investigators or hospital staff,
  • body mass index>40 kg/m2
  • patients undergoing bilateral surgery,
  • History of coagulopathies
  • creatinine>1.5 mg/dL
Show all 10Show fewer
  • American Society of Anesthesia (ASA) III-IV
  • Any contraindication to regional anesthesia
  • Unstable vital data
  • Head or chest trauma will be excluded.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain shams university

    Cairo, 11566

Other trials in Egypt

About this study

Official title: SOFT Block Versus Spinal Anesthesia in Patients Undergoing Surgery for Fixation of Open Tibial Fractures Using Ilizarov External Fixator

Peripheral nerve block is an ideal choice for lower limb surgery because of the peripheral site of the surgical procedure and the ability to block pain pathways at multiple levels. On the contrary to other anesthetic techniques, as spinal or general anesthesia, properly performed peripheral nerve blocks bypass adverse events as hemodynamic instability and respiratory complications, properly treat post-operative pain leading to early hospital discharge. Additional advantages of peripheral nerve blocks are that they can be used in patients receiving anti-coagulants or lumbosacral disease in addition to avoidance of airway instrumentation.

Recently, there has been a significant interest in regional anesthesia and peripheral nerve blockade. This is facilitated by a significant advance of the research in this field and availability of better equipment facilitating regional anesthesia.The aim of this study was to assess the efficacy and safety of SOFT block (sciatic-obturator-femoral nerve block technique) in comparison with spinal anesthesia in patients undergoing surgery for fixation of open tibial fractures using Ilizarov external fixator.

Read the detailed description

After the approval of medical ethical committee of Ain Shams University, this prospective parallel group double blinded study will be conducted over 60 patients between the age of 35-57 years old, ASA physical status I and II, scheduled for fixation of open tibial fractures using iIlizarov external fixator. at Ain Shams University hospitals in 2018-2019, After written informed consent is obtained.

Refusal to participate, inability to communicate with the investigators or hospital staff, obesity (body mass index>40 kg/m2), patients undergoing bilateral surgery, patients with coagulopathies ,renal insufficiency (creatinine>1.5 mg/dL), American Society of Anesthesia (ASA) III-IV, patients with any contraindication to regional anesthesia , patients with unstable vital data and patients with head or chest trauma will be excluded.

Preanesthetic check will be done at night of surgery. After an intravenous (IV) cannula will be secured , and midazolam 0.05 mg/kg i.v. will be given to all patients before transfer to the operating room where standard monitoring devices as ECG,Non invasive blood pressure and pulse oximetry will be placed. Then, patients will be randomly allocated by sealed envelope technique to receive either spinal anesthesia or SOFT block. In spinal anesthesia group, patients will receive spinal anesthesia with hyperbaric bupivacaine 0.5% (7.5-10mg). This will be administered via a 25-G spinal needle at L4-L5 or L3-L4 with the patient in the sitting position under complete aseptic conditions.

In SOFT group, patients will receive SOFT block where patients will be positioned in supine position,under aseptic conditions, a linear US probe will be placed on the inguinal crease to show the femoral nerve and vessels. Using an in-plane technique, a 12-cm stimulating block needle will be introduced medial to the femoral vein and advanced 1-3 cm below and parallel to the skin. Then, It will be redirected toward the fibres of the femoral nerve, where 15 mL of bupivacaine 0.25% will be injected. To block the obturator nerve, the probe will be shifted medially, superior to the needle, and directed cranially to identify the pectineus muscle . The needle will be then withdrawn to the subcutaneous tissue and redirected using an out-of-plane technique toward the deep surface of the pectineus, where 10 mL of bupivacaine 0.25%will be injected.[4 ] To locate the sciatic nerve, we will use the curvilinear probe, directed it inferior to the needle, and tilted the probe to get the clearest image of the sciatic nerve.The needle will be inserted then withdrawn subcutaneously and directed by an in-plane technique toward the sciatic nerve deep to the inferior border of the quadratus femoris muscle. Then 20 mL of bupivacaine 0.25% will be injected after needle elicited muscle twitches using 1 mA current.

Sensory level will be evaluated by loss of pinprick sensation (20-gauge hypodermic needle).

Haemodynamic variables will be recorded every 5 min after block performance until the end of surgery. Hypotension will be defined as a decrease in systolic arterial blood pressure by 30% or more from baseline values, and it will be initially treated with 200 ml IV infusion of Ringer's lactate solution; if this proved to be ineffective, an IV bolus of phenylephrine (40-50 mcg) will be given. Bradycardia is defined as heart rate decrease below 45 bpm, and it was treated with 0.5 mg IV atropine.

Sensory block(loss of pinprick sensation at T12 in the Spinal group, or in the femoral, obturator and sciatic nerves distribution in the SOFT group). The quality of the block will be judged according to the need for supplementary IV analgesics and sedation: adequate nerve block = neither sedation nor analgesics required to complete surgery; inadequate nerve block = need for rescue dose of analgesic (100 mg IV bolus of ketamine) or sedation (3mg IV midazolam) will be required to complete surgery; failed nerve block so general anesthesia will be required to complete surgery.

After completion of surgery, patients will be transferred to the post-anesthesia care unit (PACU). Intravenous pethidine (50 mg) will be given as rescue analgesic as needed. Primary endpoint is the time from the end of local anaesthetic injection to complete resolution of sensory block. The secondary endpoints include patient satisfaction, (on a numerical rating scale), the adverse events as back pain, postural -puncture headache , vomiting, adverse events of systemic toxicity from local anesthetic as seizures and cardiovascular collapse, persistent parasthesia observed within 48 hours after the block and failure rate of the block will be recorded.

In case of failure of the block or incidence of seizures resulting from local anesthetic toxicity , we will convert to general anesthesia.

In case of cardiovascular collapse, support the patient with intravenous fluids and vasopressors as required so in these cases patients will be excluded from the study.

Conditions
Pain, Acute
Being tested
SOFT block group, spinal anesthesia group
Medical subject headings
Acute Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SOFT block groupDevice

    needle will be introduced medial to the femoral vein and 3 cm below the skin where 15 mL of bupivacaine 0.25% injected. the obturator nerve, the probe shifted medially, superior to the needle, and directed cranially to the pectineus muscle . Needle withdrawn to the subcutaneous tissue and redirected using out-of-plane toward the deep surface of pectineus, 10 mL of bupivacaine 0.25%will be injected. The sciatic nerve, we use the curvilinear probe, inferior to the needle, and tilted the probe to get the clearest image of the sciatic nerve.The needle will be inserted then withdrawn subcutaneously and directed by an in-plane toward the sciatic nerve deep to the inferior border of the quadratus femoris muscle.20 mL of bupivacaine 0.25% will be injected

  • spinal anesthesia groupDevice

    patients will receive spinal anesthesia with hyperbaric bupivacaine 0.5% (7.5-10mg). This will be administered via a 25-G spinal needle at L4-L5 or L3-L4 with the patient in the sitting position under complete aseptic conditions.

Study groups in NCT03450798
Study groupRoleWhat they receive
SOFT block groupActive comparatorneedle will be introduced medial to the femoral vein and 3 cm below the skin where 15 mL of bupivacaine 0.25% injected. the obturator nerve, the probe shifted medially, superior to the needle, and directed cranially to the pectineus muscle . Needle withdrawn to the subcutaneous tissue and redirected using out-of-plane toward the deep surface of pectineus, 10 mL of bupivacaine 0.25%will be injected. The sciatic nerve, we use the curvilinear probe, inferior to the needle, and tilted the probe to get the clearest image of the sciatic nerve.The needle will be inserted then withdrawn subcutaneously and directed by an in-plane toward the sciatic nerve deep to the inferior border of the quadratus femoris muscle.20 mL of bupivacaine 0.25% will be injected
Receives: Device: SOFT block group
spinal anesthesia groupSham comparatorpatients will receive spinal anesthesia with hyperbaric bupivacaine 0.5% (7.5-10mg). This will be administered via a 25-G spinal needle at L4-L5 or L3-L4 with the patient in the sitting position under complete aseptic conditions.
Receives: Device: spinal anesthesia group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. T- test of the recovery time(duration of analgesia)mean±SD

    It is the time from the end of local anaesthetic injection to complete resolution of sensory block

    Measured: 3-12 hours

Secondary outcomes (2)
  1. Review of medical records for postoperative complications

    persistent parasthesia

    Measured: 48 hours after the procedure

  2. Failure of the block

    general anesthesia will be required to complete surgery.

    Measured: 50 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Mar 2018
  2. Study start10 Feb 2018
  3. Primary completion10 Jan 2019
  4. Study completion10 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
107 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03450798
Sponsor's protocol ID
FWA00001785
Status last verified
Jan 2019
First submitted
20 Feb 2018
Last updated
24 Jan 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: study protocol

Publications

  • Shokri H, Kasem AA. Sciatic obturator femoral technique versus spinal anaesthesia in patients undergoing surgery for fixation of open tibial fractures using Ilizarov external fixator. A randomised trial. BMC Anesthesiol. 2020 Jan 4;20(1):4. doi: 10.1186/s12871-019-0920-6.

    PubMed 31901231

Questions about this trial

What is this clinical trial studying?

A study testing SOFT block group and spinal anesthesia group in people with Pain, Acute, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

T- test of the recovery time(duration of analgesia)mean±SD (time frame: 3-12 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03450798, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03450798 | AzTrials